First-ever in-person PPI panel meeting for @lrcg.bsky.social @newcastleuni.bsky.social Great discussions with patients & families on ALL risk, AI in treatment, & reducing therapy. Lab tour highlight: lab coats on & excitement all around Part of BIOINFORM — @cancerresearchuk.org #Research #ALL

At #𝐈𝐂𝐊𝐒𝐇2026 in Seoul!🩸 @avmoorman.bsky.social is presenting on integrating Genetics & MRD in Acute Lymphoblastic Leukaemia🧬 🎯 Goal: Subtype-specific MRD thresholds to reduce over-treatment. 🚀 Future: Flexible risk algorithms to support novel therapies. #Leukaemia #PrecisionMedicine #Hematology

Proud to see @lrcg.bsky.social contribute to this global study in @nature.com(𝘕𝘢𝘵. 𝘊𝘰𝘮𝘮𝘶𝘯). We shared data to help refine AI that predicts leukemia subtypes from routine lab results, aiming to close global health diagnostic gaps🩸🌍 Read: doi.org/10.1038/s414... #Leukemia #AI #NewcastleUni

Great to be at the Annual Conference of @cclguk.bsky.social in Manchester. Prof. @avmoorman.bsky.social shared how the VIVO Biobank supports acute leukaemia research, highlighting key research from @lrcg.bsky.social, including the UKALL CNA profile in the ALLTogether trial.🧬🤝

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒊𝒏𝒈 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 𝑳𝒚𝒎𝒑𝒉𝒐𝒃𝒍𝒂𝒔𝒕𝒊𝒄 𝑳𝒆𝒖𝒌𝒂𝒆𝒎𝒊𝒂 (𝑩-𝑨𝑳𝑳) 𝒓𝒆𝒔𝒆𝒂𝒓𝒄𝒉🧬 Our group lead @avmoorman.bsky.social presented on risk stratification in B-ALL at the International ALL Assembly, sponsored by @amgen.bsky.social. Great opportunity to share our work with the international research community.

Excited to share our evaluation of the TALLSorts classifier!🧬 Our research letter validates its utility against standard DNA methods for paediatric T-ALL, demonstrating high concordance✅ Published now in British Journal of Haematology @wiley.com. Read here: onlinelibrary.wiley.com/doi/10.1111/...

Sharing a great 𝐏𝐡𝐃 𝐒𝐭𝐮𝐝𝐞𝐧𝐭𝐬𝐡𝐢𝐩 opportunity in 𝐁𝐢𝐨𝐬𝐞𝐧𝐬𝐨𝐫 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐟𝐨𝐫 𝐂𝐚𝐧𝐜𝐞𝐫 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠. This multidisciplinary project focuses on developing next-generation biosensors for cancer monitoring and offers full funding for up to four years. Click for more information: www.ncl.ac.uk/postgraduate...

Search for Postgraduate Scholarships and Other Funding

Search scholarships and funding for postgraduate study at Newcastle University. Find financial support tailored to your course and eligibility.

ncl.ac.uk

We’re proud to see our Prof Christine Harrison featured speaking with His Royal Highness The Duke of Kent during one of his visits to @newcastleuni.bsky.social. We join @bloodcanceruk.bsky.social in wishing His Royal Highness a very happy 90th birthday 🎉🎂 and thanking him for his support.

Last month in Madrid, the ALLTogether1 trial brought Europe’s teams roundtable. @avmoorman.bsky.social and other LRCG members shared genetics work to sort risk better and tailor treatment in ALL. Days like this remind us: good collaboration turns into patient impact. @newcastleuni.bsky.social

From the North East: a cancer survivor who became a doctor - proof that resilience + research change lives. With CRUK’s £4.1m boost to @newcastleuni.bsky.social, LRCG is excited to turn hope into outcomes. To the individual: your courage lifts us all. Read at www.chroniclelive.co.uk/news/north-e...

Lad diagnosed with cancer at 14 achieves dream of becoming doctor

Cramlington-born Dan Mattison has become a doctor - fulfilling an ambition he has had since a teenage cancer diagnosis

chroniclelive.co.uk

BIOINFORM (£2.7m @crukpolicy.bsky.social project) will: build CRISTAL (shared clinical/genomic data portal), develop AI risk tools to guide therapy, study new genetic changes in ALL, and map the genomics of childhood AML — so each patient gets the most effective, least toxic treatment.

Exciting milestone as we held BIOINFORM project kick-off at @newcastleuni.bsky.social, funded by @crukpolicy.bsky.social. The day began with presentations tracing the history of LRCG and introducing the different work packages that will drive the BIOINFORM project forward. @avmoorman.bsky.social